MiraQ cardiac TTFM with high-frequency probe for assessing graft flow during coronary

levels of lipoprotein(a), smoking, physical inactivity, diabetes and being overweight increase the risk of developing coronary heart disease. Older people, people who are male and people of South Asian family origin are also more likely to develop coronary heart disease. Age, disability, sex and race are protected characteristics under the Equality Act 2010. Clinical and technical evidence A literature search was carried out for this briefing in accordance with the interim process and methods statement for medtech innovation briefings. This briefing includes the most relevant or best available published evidence relating to the clinical effectiveness of the technology. Further information about how the evidence for this briefing was selected is available on request by contacting mibs@nice.org.uk. Published evidence Four studies are summarised in this briefing, which include a total of 1,134 people. All studies are single-arm studies without a comparator. The evidence consists of 1 multicentre observational registry (Taggart et al. 2020), which has 1 secondary analysis from this data (Rosenfeld et al. 2021a), 1 prospective study (Wendt et al. 2019) and 1 retrospective observational study (Kim et al. 2020). There is 1 secondary analysis that is not summarised below because it includes people with chronic and end-stage renal disease
